Independence Wealth Advisors (Ohio)’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$420K Buy
2,679
+256
+11% +$38.4K 0.21% 52
2026
Q1
$370K Buy
2,423
+685
+39% +$105K 0.2% 55
2025
Q4
$240K Buy
+1,738
New +$228K 0.13% 76

Other funds holding NVS

Independence Wealth Advisors (Ohio)'s NVS Position: Q2 2026 in Review

Independence Wealth Advisors (Ohio) increased its Novartis (NVS) stake by 11% in Q2 2026, buying an estimated $38.4K and bringing the position to 2,679 shares worth $420K. The position accounts for 0.21% of the portfolio, ranked #52.

Independence Wealth Advisors (Ohio) first reported a position in NVS in Q4 2025 and has held it in 3 quarters since. 1,614 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Independence Wealth Advisors (Ohio) held 2,679 shares of Novartis worth $420K as of Q2 2026.
  • Independence Wealth Advisors (Ohio) bought 256 Novartis shares in Q2 2026, an estimated $38.4K.
  • Novartis made up 0.21% of Independence Wealth Advisors (Ohio)'s portfolio in Q2 2026, its #52 holding.
  • Independence Wealth Advisors (Ohio) first reported a position in Novartis in Q4 2025 and has held it in 3 quarters since.
  • 1,614 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Independence Wealth Advisors (Ohio)'s 13F filing for Q2 2026, filed 14 Aug 2026.